{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:22:22Z","timestamp":1785280942774,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Swedish Heart and Lung Foundation, Lund University, Lund, Sweden"},{"name":"Skane University Hospital, Lund, Sweden"},{"name":"Region of Scania, Sweden"},{"name":"Medical Faculty, Lund University, Lund, Sweden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0756-x","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T07:44:04Z","timestamp":1517298244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5063-3514","authenticated-orcid":false,"given":"Tom","family":"Gyllenhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Kanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Engblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Wuttge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hesselstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Arheden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"756_CR1","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809\u201315.","journal-title":"Ann Rheum Dis"},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","volume":"112","author":"Y Shoenfeld","year":"2005","unstructured":"Shoenfeld Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337\u201347.","journal-title":"Circulation"},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437\u201344.","journal-title":"Arthritis Rheum"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/ard.2006.066340","volume":"67","author":"L Czirj\u00e1k","year":"2008","unstructured":"Czirj\u00e1k L, Kum\u00e1novics G, Varj\u00fa C, Nagy Z, P\u00e1kozdi a SZ, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis. 2008;67:59\u201363.","journal-title":"Ann Rheum Dis"},{"key":"756_CR5","doi-asserted-by":"crossref","unstructured":"Elhai M, Meune C, Avouac J, Kahan A, Allanore Y. Trends In mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2012;51 September 2011:1017\u20131026.","DOI":"10.1093\/rheumatology\/ker269"},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/rheumatology\/kel120","volume":"45","author":"MR Akram","year":"2006","unstructured":"Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology. 2006;45:1395\u20138.","journal-title":"Rheumatology"},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/art.30380","volume":"63","author":"K Au","year":"2011","unstructured":"Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum. 2011;63:2078\u201390.","journal-title":"Arthritis Rheum"},{"key":"756_CR8","first-page":"8","volume":"3","author":"F Cannarile","year":"2015","unstructured":"Cannarile F, Valentini V, Mirabelli G, Alunno A, Terenzi R, Luccioli F, et al. Cardiovascular disease in systemic sclerosis. Ann Transl Med. 2015;3:8.","journal-title":"Ann Transl Med"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/BOR.0b013e328313bcf1","volume":"20","author":"Y Allanore","year":"2008","unstructured":"Allanore Y, Meune C, Kahan A. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies. Curr Opin Rheumatol. 2008;20:697\u2013702.","journal-title":"Curr Opin Rheumatol"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1871528114666150916112551","volume":"14","author":"SI Mavrogeni","year":"2015","unstructured":"Mavrogeni SI, Bratis K, Karabela G, Spiliotis G, Van wijk K, Hautemann D, et al. Cardiovascular magnetic resonance imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis. Inflamm Allergy - Drug Targets. 2015;14:29\u201336.","journal-title":"Inflamm Allergy - Drug Targets"},{"key":"756_CR11","doi-asserted-by":"crossref","unstructured":"Rodriguez-Reyna TS, Morelos-Guzman M, Hernandez-Reyes P, Montero-Duarte K, Martinez-Reyes C, Reyes-Utrera C, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology. 2014;","DOI":"10.1093\/rheumatology\/keu350"},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1532-429X-12-57","volume":"12","author":"M Jerosch-Herold","year":"2010","unstructured":"Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:57.","journal-title":"J Cardiovasc Magn Reson"},{"key":"756_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/hrt.30.1.105","volume":"30","author":"WB Hood","year":"1968","unstructured":"Hood WB. Regional venous drainage of the human heart. Br Heart J. 1968;30:105\u20139.","journal-title":"Br Heart J"},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1161\/01.CIR.101.23.2696","volume":"101","author":"J Schwitter","year":"2000","unstructured":"Schwitter J, DeMarco T, Kneifel S, von Schulthess GK, Jorg MC, Arheden H, et al. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters : a comparison with positron emission tomography. Circulation. 2000;101:2696\u2013702.","journal-title":"Circulation"},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1148\/radiology.217.2.r00nv10487","volume":"217","author":"GK Lund","year":"2000","unstructured":"Lund GK, Wendland MF, Shimakawa A, Arheden H, St\u00e5hlberg F, Higgins CB, et al. Coronary sinus flow measurement by means of velocity-encoded cine MR imaging: validation by using flow probes in dogs. Radiology. 2000;217:487\u201393.","journal-title":"Radiology"},{"key":"756_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/jmri.1100","volume":"13","author":"H Arheden","year":"2001","unstructured":"Arheden H, Saeed M, T\u00f6rnqvist E, Lund G, Wendland MF, Higgins CB, et al. Accuracy of segmented MR velocity mapping to measure small vessel pulsatile flow in a phantom simulating cardiac motion. J Magn Reson Imaging. 2001;13:722\u20138.","journal-title":"J Magn Reson Imaging"},{"key":"756_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2342-9-9","volume":"9","author":"KM Bloch","year":"2009","unstructured":"Bloch KM, Carlsson M, Arheden H, St\u00e5hlberg F. Quantifying coronary sinus flow and global LV perfusion at 3T. BMC Med Imaging. 2009;9:9.","journal-title":"BMC Med Imaging"},{"key":"756_CR18","doi-asserted-by":"crossref","unstructured":"Carlsson M, J\u00f6gi J, Markenroth Bloch K, Hed\u00e9n B, Ekelund U, St\u00e5hlberg F, et al. Submaximal adenosine induced coronary hyperemia with 12 hours caffein abstinence; implications for clinical adenosine perfusion imaging tests. Clin Physiol Funct Imaging. 2013","DOI":"10.1111\/cpf.12125"},{"key":"756_CR19","doi-asserted-by":"crossref","unstructured":"Gyllenhammar T, Fernlund E, Jablonowski R, J\u00f6gi J, Engblom H, Liuba P, et al. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR. Eur Heart J Cardiovasc Imaging. 2014;","DOI":"10.1093\/ehjci\/jeu137"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"756_CR21","doi-asserted-by":"crossref","unstructured":"Heiberg E, Sj\u00f6gren J, Ugander M, Carlsson M, Engblom H, Arheden H. Design and validation of segment - freely available software for cardiovascular image analysis. BMC Med Imaging. 2010;10(1)","DOI":"10.1186\/1471-2342-10-1"},{"key":"756_CR22","unstructured":"Segment version 2.0 R5014. http:\/\/segment.heiberg.se . Accessed 1 Jan 2018."},{"key":"756_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","volume":"46","author":"WA D\u2019Angelo","year":"1969","unstructured":"D\u2019Angelo WA, Fries JF, AT M, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). Am J Med. 1969;46:428\u201340.","journal-title":"Am J Med"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00259-003-1344-5","volume":"31","author":"SR Underwood","year":"2004","unstructured":"Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging. 2004;31:261\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"756_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12968-017-0388-9","volume":"19","author":"H Engblom","year":"2017","unstructured":"Engblom H, Xue H, Akil S, Carlsson M, Hindorf C, Oddstig J, et al. Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography. J Cardiovasc Magn Reson. 2017;19:78.","journal-title":"J Cardiovasc Magn Reson"},{"key":"756_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/art.1780280607","volume":"28","author":"A Kahan","year":"1985","unstructured":"Kahan A, Nitenberg A, Foult J-M, Amor B, Menkes C-J, Devaux J-Y, et al. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum. 1985;28:637\u201346.","journal-title":"Arthritis Rheum"},{"key":"756_CR27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/ard.62.9.890","volume":"62","author":"R Montisci","year":"2003","unstructured":"Montisci R, Vacca A, Garau P, Colonna P, Ruscazio M, Passiu G, et al. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis. 2003;62:890\u20133.","journal-title":"Ann Rheum Dis"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/ar4136","volume":"15","author":"A Vacca","year":"2013","unstructured":"Vacca A, Montisci R, Garau P, Siotto P, Piga M, Cauli A, et al. Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests. Arthritis Res Ther. 2013;15:R8.","journal-title":"Arthritis Res Ther."},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/ard.2004.031484","volume":"64","author":"O Vignaux","year":"2005","unstructured":"Vignaux O, Allanore Y, Meune C, Pascal O, Duboc D, Weber S, et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis. 2005;64:1268\u201373.","journal-title":"Ann Rheum Dis"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/art.23463","volume":"58","author":"C Meune","year":"2008","unstructured":"Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58:1803\u20139.","journal-title":"Arthritis Rheum"},{"key":"756_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/ard.57.11.682","volume":"57","author":"R Hesselstrand","year":"1998","unstructured":"Hesselstrand R, Scheja a A a. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis. 1998;57:682\u20136.","journal-title":"Ann Rheum Dis"},{"key":"756_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.1780390421","volume":"39","author":"VD Steen","year":"1996","unstructured":"Steen VD, Follansbee WP, Conte CG, T a M. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum. 1996;39:677\u201381.","journal-title":"Arthritis Rheum"},{"key":"756_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-017-1370-5","volume":"19","author":"M Matucci-Cerinic","year":"2017","unstructured":"Matucci-Cerinic M, Manetti M, Bruni C, Chora I, Bellando-Randone S, Lepri G, et al. The \u201cmyth\u201d of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event? Arthritis Res Ther. 2017;19:162.","journal-title":"Arthritis Res Ther"},{"key":"756_CR34","doi-asserted-by":"crossref","unstructured":"Wermuth PJ, Carney KR, Mendoza FA, Piera-Velazquez S, Jimenez SA. Endothelial cell-specific activation of transforming growth factor-\u03b2 signaling in mice induces cutaneous, visceral, and microvascular fibrosis. Lab Investig. 2017;","DOI":"10.1038\/labinvest.2017.23"},{"key":"756_CR35","doi-asserted-by":"crossref","unstructured":"Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology. 2006;45(SUPPL. 4)","DOI":"10.1093\/rheumatology\/kel312"},{"key":"756_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.acvd.2009.06.009","volume":"103","author":"C Meune","year":"2010","unstructured":"Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis. 2010;103:46\u201352.","journal-title":"Arch Cardiovasc Dis"},{"key":"756_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ehjci\/jeu167","volume":"16","author":"A Barison","year":"2015","unstructured":"Barison A, Gargani L, De Marchi D, Aquaro GD, Guiducci S, Picano E, et al. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015;16:74\u201380.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"756_CR38","doi-asserted-by":"crossref","unstructured":"Corrado A, Correale M, Mansueto N, Monaco I, Carriero A, Mele A, et al. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. 2017.","DOI":"10.1136\/annrheumdis-2017-eular.5091"},{"key":"756_CR39","doi-asserted-by":"crossref","unstructured":"Gigante A, Barbano B, Barilaro G, Quarta S, Gasperini ML, Di Mario F, et al. Serum uric acid as a marker of microvascular damage in systemic sclerosis patients. Microvasc Res. 2016;","DOI":"10.1016\/j.mvr.2016.03.007"},{"key":"756_CR40","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3899\/jrheum.161092","volume":"44","author":"S Sato Saigusa","year":"2017","unstructured":"Sato Saigusa S, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Taniguchi T, et al. vasculopathy in systemic sclerosis endothelial cells, contributing to the development of fibrosis and Fli1 deficiency induces CXCL6 expression in dermal fibroblasts and Fli1 deficiency induces CXCL6 expression in dermal fibroblasts and endothelial cells. J Rheumatol. 2017;44:1198\u2013205.","journal-title":"J Rheumatol"},{"key":"756_CR41","unstructured":"Epigenetic AY. Suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis. Int J Biochem Cell Biol. 2015;"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0756-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T19:47:42Z","timestamp":1570650462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0756-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0756-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"19 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the regional ethics committee, Lund, Sweden. The reference number is 2013\/319. Written informed consent was obtained from the subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HA is a shareholder of Imacor AB, Lund. HE and MC have received consultancy fees from Imacor AB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"16"}}